Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

Aptorum Group Announces Publication Of A Co-Authored Paper On Its PathsDx Technology, A Rapid-Turnaround Low-Depth Unbiased Metagenomics Sequencing Workflow For Liquid Biopsy Based Diagnosis Of Infectious Diseases On Illumina Platforms

Regulatory News: Aptorum Group Limited (NASDAQ:APM, PARIS:APM) a clinical stage biopharmaceutical company dedicated to tackling unmet medical needs in oncology, autoimmune and infectious diseases, is pleased to announce

APM